| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/05/2013 | CN103127189A Method for preparing total flavones extract product of Abelmoschl Manihot |
| 06/05/2013 | CN103127188A Traditional Chinese medicine cratoxylum cochinchinense root medicinal slice, preparation method and application thereof |
| 06/05/2013 | CN103127179A Anti-inflammatory drug peat acid extraction method |
| 06/05/2013 | CN103127170A Formula of insecticidal haemorrhoid medicine and preparation method of insecticidal haemorrhoid medicine |
| 06/05/2013 | CN103127168A Hydropathic compress paste containing magnesium sulfate as well as preparation method and application of paste |
| 06/05/2013 | CN103127165A Inhalation analgesic and manufacture method and application thereof |
| 06/05/2013 | CN103127164A Application of k-carrageenan oligosaccharides capable of adjusting activated states of gitter cell |
| 06/05/2013 | CN103127155A Application of solasodine hydrochloride as pain treatment medicine |
| 06/05/2013 | CN103127154A Application of Gypensapogenin A in medicines resisting aseptic inflammation |
| 06/05/2013 | CN103127145A Medicine composition containing triamcinolone acetonide acetate and nitric oxide synthase (NOS) inhibitor and for treating nose inflammation |
| 06/05/2013 | CN103127142A Dermal medicine composition containing mometasone furoate and amino acid derivative |
| 06/05/2013 | CN103127139A Difluprednate topical external preparation |
| 06/05/2013 | CN103127137A Medicine combination with hydrocortisone butyrate and nitric oxide synthase (NOS) inhibitor and for treating skin inflammation |
| 06/05/2013 | CN103127136A Skin drug composition containing methylprednisolone aceponate and amino acid |
| 06/05/2013 | CN103127134A Medicine composition containing fluticasone propionate and nitric oxide synthase (NOS) inhibitor and for treating nose inflammation |
| 06/05/2013 | CN103127132A Dermal medicine composition containing fluticasone propionate and nitric oxide synthase (NOS) inhibitor |
| 06/05/2013 | CN103127126A 1-[4-[3-(4-morpholinyl)propoxy]-2-hydroxy phenyl]-3-(4-morpholinyl)-2-propylene-1-one and application thereof |
| 06/05/2013 | CN103127125A Paracetamol and caffeine dry suspension and preparation method thereof |
| 06/05/2013 | CN103127113A Compound pseudoe-phedrine hydro-chloride dry suspension and preparation method thereof |
| 06/05/2013 | CN103127095A Synthesis and application of dihydrothiophenone derivative as pfDHODH inhibitor |
| 06/05/2013 | CN103127075A Application of Aphanamixoid A to aseptic inflammation resistance medicine |
| 06/05/2013 | CN103127059A Oral administration preparation composed of bilobalide B derivative and preparation method thereof |
| 06/05/2013 | CN103127053A Medical application of 6-[2-(dimethylamino)ethoxy]flavone |
| 06/05/2013 | CN103127046A Medicine containing diacetyl rhein compound and preparation method of medicine |
| 06/05/2013 | CN103127002A Nanoparticle-loaded microsphere system for injection and preparation method of system |
| 06/05/2013 | CN103126984A Difluprednate emulsion |
| 06/05/2013 | CN103126800A Zinc-citric acid heating system in medicinal compressing patch |
| 06/05/2013 | CN103126793A Chinese medicinal herb fracture fixation splint |
| 06/05/2013 | CN102764269B Nasal cavity health care cleansing solution and preparation method thereof |
| 06/05/2013 | CN102631594B Medicament for treating rheumatoid arthritis |
| 06/05/2013 | CN102525907B Tectorigenin sodium sulfonate injection |
| 06/05/2013 | CN102512530B Externally applied traditional Chinese medicine for treating acute closed sports injury |
| 06/05/2013 | CN102488818B Pharmaceutical composition for treating rheumatism and rheumatoid arthritis |
| 06/05/2013 | CN102430068B Vinegar and traditional Chinese medicine combined fomentation vinegar with functions of removing stasis, invigorating kidneys and treating arthralgia and preparation method thereof |
| 06/05/2013 | CN102430018B Medicinal composition for treating rheumatic and rheumatoid arthritis |
| 06/05/2013 | CN102429756B Close-fitting magnetic breathable waistband |
| 06/05/2013 | CN102397305B Preparation method of medicament for treating arthralgia and myalgia |
| 06/05/2013 | CN102380072B Externally applied cold wash traditional Chinese medicine composition for activating blood and reliving pain and application thereof |
| 06/05/2013 | CN102357191B Pharmaceutical composition for treating hashimoto disease |
| 06/05/2013 | CN102344408B Double-effect anesthetic |
| 06/05/2013 | CN102343045B Medicinal composition for treating rheumatoid arthritis and preparation method thereof |
| 06/05/2013 | CN102343018B Ointment for treating soft tissue sprain and contuse |
| 06/05/2013 | CN102335386B Chinese medicinal composition for dispersing qi depression, promoting appetite, removing stagnation and stopping pain and preparation method thereof |
| 06/05/2013 | CN102335326B Chinese medicinal composition for invigorating circulation of blood to dissipate blood stasis and reducing swelling and relieving pain |
| 06/05/2013 | CN102335304B Chinese medicine composition for dispelling wind, removing dampness, invigorating blood circulation, and relieving pain and preparation method thereof |
| 06/05/2013 | CN102274462B Traditional Chinese medicine ointment for treating traumatic sore |
| 06/05/2013 | CN102274200B Diclofenac sodium sustained release tablets and preparation process thereof |
| 06/05/2013 | CN102266503B Sugar-free anemopyretic cold granules and preparation method thereof |
| 06/05/2013 | CN102266398B Composition for mud moxibustion of rheumatic diseases |
| 06/05/2013 | CN102225125B Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof |
| 06/05/2013 | CN102180837B Secnidazole derivative as well as preparation method and application thereof |
| 06/05/2013 | CN102145090B Traditional Chinese medicinal composition for eliminating wind and relieving heat and preparation method thereof |
| 06/05/2013 | CN102083832B Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 Tachikynin receptor antagonists |
| 06/05/2013 | CN101991484B Wound pain quick recovery application instrument |
| 06/05/2013 | CN101906104B 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 06/05/2013 | CN101583601B Isoquinolone compounds as subtype-selective agonists for melatonin receptors mt1 and mt2 |
| 06/05/2013 | CN101564514B Method for analyzing children Fengreqing particle |
| 06/05/2013 | CN101535289B Novel phenylacetic acid derivative |
| 06/05/2013 | CN101474277B Medicine composition for rheumatism and its preparation |
| 06/05/2013 | CN101460624B Sense oligonucleotide capable of controlling the expression of iNOS and composition comprising the same |
| 06/05/2013 | CN101355947B Thiazolopyrimidines for use in therapy |
| 06/04/2013 | US8455553 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease and transplant rejection |
| 06/04/2013 | US8455536 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
| 06/04/2013 | US8455517 Method of using diketopiperazines and composition containing them |
| 06/04/2013 | US8455511 Pyrrolopyridine derivatives substituted with cyclic amino group |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455489 Substituted pyrimidine compositions and methods of use |
| 06/04/2013 | US8455445 Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders |
| 06/04/2013 | US8455437 Method to predict and prevent oxygen-induced inflammatory tissue injury |
| 06/04/2013 | CA2583517C Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkaline agent for enhanced absorption |
| 06/04/2013 | CA2545659C Bicyclic inhibitors of mek |
| 05/30/2013 | WO2013078430A1 Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa) |
| 05/30/2013 | WO2013077228A1 Impdh inhibitor having microrna as active component |
| 05/30/2013 | WO2013077186A1 Activity modulator, medicinal agent comprising same, use of cd300a gene-deficient mouse, and anti-cd300a antibody |
| 05/30/2013 | WO2013076487A1 Phytocannabinoids for use in the treatment of intestinal inflammatory diseases |
| 05/30/2013 | WO2013075596A1 Pentabasic dihydrogen heterocyclic ketone derivative as dhodh inhibitor and use thereof |
| 05/30/2013 | WO2013075391A1 Electromagnetic therapeutic apparatus and supporting physiotherapy liquid thereof |
| 05/30/2013 | WO2013012806A3 Protection of cells from alu-rna-induced degenereation and inhibitors for protecting cells |
| 05/30/2013 | US20130136798 Novel parenteral controlled release formulations of nsaid's |
| 05/30/2013 | US20130136775 Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition |
| 05/30/2013 | US20130136751 Methods, Compositions and Kits Relating to Chitnases and Chitnase-Like Molecules and Inflammation Disease |
| 05/30/2013 | US20130136714 Functionalized polymer nanoparticles and the pharmaceutical use thereof |
| 05/30/2013 | CA2856582A1 Il-1 binding proteins |
| 05/30/2013 | CA2856522A1 Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa) |
| 05/29/2013 | EP2596784A1 Tapentadol compositions |
| 05/29/2013 | EP2595991A2 METHODS AND COMPOSITIONS FOR INHIBITING THE NUCLEAR FACTOR kB PATHWAY |
| 05/29/2013 | EP2595975A2 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex |
| 05/29/2013 | EP2595964A1 Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them |
| 05/29/2013 | EP2595959A1 Sulfonyl compounds which modulate the cb2 receptor |
| 05/29/2013 | EP2595957A1 Pyridin- 2 - yl sulfanyl acid esters and process for the preparation thereof |
| 05/29/2013 | EP2595637A2 Regulatory immune cells with enhanced targeted cell death effect |
| 05/29/2013 | EP2595624A2 Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects |
| 05/29/2013 | EP2595620A2 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf |
| 05/29/2013 | EP2595615A1 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| 05/29/2013 | CN1911965B Binding domain-immunoglobulin fusion proteins |
| 05/29/2013 | CN1525866B Treatment using neublastin polypeptides |
| 05/29/2013 | CN103122001A Polo-like kinase inhibitors |
| 05/29/2013 | CN103121996A Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors |
| 05/29/2013 | CN103121986A Crystal form E of 7-hydroxyisoflavone and preparation method thereof, and pharmaceutical composition and application thereof |
| 05/29/2013 | CN103121972A Pyrimidine urea derivatives as kinase inhibitors |